| CNSP Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CNSP shares outstanding history going back to 11/8/2019:
Also see: CNSP Market Cap History CNSP YTD Return |
CNSP Shares Outstanding History — CNS Pharmaceuticals Share Count Over Time
As of 5/13/2026 CNS Pharmaceuticals has 1.46 million CNSP shares outstanding. Investors often track the CNSP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CNSP share count trends over time, with 31 historical shares outstanding datapoints presented, dating back to 11/8/2019.
| CNSP Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CNSP Historical Shares Outstanding: +467.39% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CNSP Stock Price Chart |
| About CNS Pharmaceuticals Inc |
| CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). Co.'s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. We show 31 historical shares outstanding datapoints in our coverage of CNSP's shares outstanding history. Understanding the changing numbers of CNSP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CNSP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CNSP by allowing them to research CNSP shares outstanding history as well as any other stock in our coverage universe. |
| CNSP Current Stock Quote |
Quotes delayed 20 minutes  Free CNSP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CNSP Share Performance |
| Shares Outstanding Peers |
| CNS Pharmaceuticals (CNSP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CNST Shares Outstanding History CNTX Shares Outstanding History CNVY Shares Outstanding History COCP Shares Outstanding History CODX Shares Outstanding History COGT Shares Outstanding History COLL Shares Outstanding History COM Shares Outstanding History CON Shares Outstanding History COO Shares Outstanding History More Healthcare companies » |
CNSP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
